Azenta, Inc.
Financials
Valuation Metrics
Azenta, Inc.'s Market Cap is $1.71B. At end of 2025 it was $1.53B. Ranked #2065 of 3,116 in US market (top 66%), #792 of 1,472 on NASDAQ (top 54%), #128 of 203 in Health Care Equipment & Services (top 63%) by Market Cap.
Investment Metrics(as of 2026-10-30)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $1.71B | US#2,065/3,116 Sec#128/203 |
| Revenue | $614M | US#2,149/3,116 Sec#135/203 |
| Net Income | $-123M | US—/3,116 Sec—/203 |
| Total Assets | $1.88B | US#2,119/3,116 Sec#109/203 |
| Net Assets | $1.51B | US#1,460/3,116 Sec#75/203 |
| Employees | 3,000 | US#1,468/3,116 Sec#104/203 |
| Value | ||
| P/B | 1.13x | US#594/3,116 Sec#22/203 |
| P/S | 2.79x | US#1,671/3,116 Sec#112/203 |
| FCF Yield | 0.58% | US#2,210/3,116 Sec#136/203 |
| Profitability | ||
| ROE | -8.14% | US#2,325/3,116 Sec#131/203 |
| ROA | -6.55% | US#2,577/3,116 Sec#146/203 |
| Op. Margin | -3.49% | US#2,420/3,116 Sec#142/203 |
| Revenue Growth | 4.85% | US#1,782/3,116 Sec#133/203 |
| Financial Health | ||
| Debt Ratio | 24.24% | US#269/3,116 Sec#25/203 |
| Total Debt | $54M | US#2,587/3,116 Sec#155/203 |
| FCF | $10M | US#2,228/3,116 Sec#138/203 |
| Cash | $190M | US#1,771/3,116 Sec#107/203 |
| Current Ratio | 2.50x | US#957/3,116 Sec#96/203 |
| Dividend | ||
| Div. Yield | 0.00% | US—/3,116 Sec—/203 |
| Div. Growth | -75.01% | US—/3,116 Sec—/203 |
| Payout Ratio | 0.00% | US—/3,116 Sec—/203 |
| Performance | ||
| 1Y Return | 30.64% | US#714/3,116 Sec#69/203 |
| 1M Return | 11.95% | US#218/3,116 Sec#24/203 |
| From 52W High | -15.84% | US#933/3,116 Sec#86/203 |
| 1Y MDD | -60.94% | US#2,748/3,116 Sec#172/203 |
| Trading | ||
| Volume | 871,060 shares | US#1,780/3,116 Sec#123/203 |
| Trading Value | $34M | US#1,662/3,116 Sec#118/203 |
| Per Share | ||
| EPS | $-2.81 | US—/3,116 Sec—/203 |
| BPS | $34.47 | US#766/3,116 Sec#50/203 |
Company Info
Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. It operates through Sample Management Solutions and Multiomics segments. The Sample Management Solutions segment provides sample management products and services, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sample repository services. This segment also offers consultation services to clients throughout their experimental design and implementation processes. The Multiomics segment provides genomic and other sample analysis services comprising gene sequencing, gene synthesis, and related services. The company has a strategic partnership with Frontier Space Ltd to conduct scientific experiments in space. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.